Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Legal status (US): Tesamorelin is FDA-approved under the brand names Egrifta and Egrifta WR, manufactured by Theratechnologies, specifically to reduce excess visceral abdominal fat in HIV-infected patients with lipodystrophy
Safety during pregnancy and breastfeeding may vary
People naturally want faster recovery and shortcuts to better performance
It works by attaching itself to GHRH receptors in the anterior pituitary gland, which leads to the activation of a signaling pathway known as cAMP, or cyclic adenosine monophosphate
US$ 29.01
US$ 25.79
US$ 26.21
US$ 28.27
US$ 24.39
US$ 22.05
US$ 27.90
